The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

A groundbreaking study highlights a new molecular approach to reversing hair loss, offering hope for treatments without ...

Up to 40% of ER-positive breast cancers have a PIK3CA mutation and are associated with poor prognosis; this approval helps address an urgent unmet need2-4 Itovebi is the first PI3K-targeted therapy to ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...